AnkenyRADaviesGKirkRGW, et al.Lessons for the future of NAMs from history, philosophy and social studies of science. Altern Lab Anim2024; 52: 276–284.
2.
GroffKAllenDCaseyW, et al.Progress and remaining opportunities to increase the use of animal-free antibodies in the USA. Altern Lab Anim2024; 52: 285–289.
3.
BramwellLRGouldSJDaviesM, et al.An evaluation of the replacement of animal-derived biomaterials in human primary cell culture. Altern Lab Anim2024; 52: 247–260.
4.
PôbišPKubalcováJMilasováT, et al. Development of sensitive in vitro protocols for the biocompatibility testing of medical devices and pharmaceuticals intended for contact with the eyes: Acute irritation and phototoxicity assessment. Altern Lab Anim2024; 52: 261–275.
